Cholesgen Pharmaceutical Overview
- Year Founded
-
2021

- Status
-
Private
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14.3M
- Investors
-
4
Cholesgen Pharmaceutical General Information
Description
Developer of innovative drugs designed for metabolic diseases and tumor treatment-related diseases. The company integrates the reporter gene screening system based on the target regulation mechanism, the protein small molecule interaction system, and the in vitro drug efficacy test system based on the target function in the research and development of new drugs, and builds an independent research and development platform for biochemical and cell testing to optimize drugs in an all-round way and promote them efficiently In-depth and development of drug research and development, providing medical industry users with innovative drug solutions.
Contact Information
Website
www.cholesgen.comCorporate Office
- No. 1077 Zhangheng Road, Pudong New Area
- Shanghai, 201103
- China
Corporate Office
- No. 1077 Zhangheng Road, Pudong New Area
- Shanghai, 201103
- China
Cholesgen Pharmaceutical Timeline
Cholesgen Pharmaceutical Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Early Stage VC (Series A) | 30-May-2023 | $14.3M | Completed | Product Development | ||
1. Seed Round | 07-Feb-2021 | Completed | Startup |
Cholesgen Pharmaceutical Patents
Cholesgen Pharmaceutical Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2023212817-A1 | Steroid compound, and preparation method therefor and application thereof | Pending | 28-Jan-2022 | ||
EP-4471046-A1 | Steroid compound, and preparation method therefor and application thereof | Pending | 28-Jan-2022 |
Cholesgen Pharmaceutical Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Dawu Venture Capital | Venture Capital | Minority | ||
Gaorong Capital | Venture Capital | Minority | ||
Wuxi AstraZeneca CICC Venture Capital Partnership | Growth/Expansion | Minority | ||
Trinity Innovation Fund | Venture Capital | Minority |
Cholesgen Pharmaceutical FAQs
-
When was Cholesgen Pharmaceutical founded?
Cholesgen Pharmaceutical was founded in 2021.
-
Where is Cholesgen Pharmaceutical headquartered?
Cholesgen Pharmaceutical is headquartered in Shanghai, China.
-
What industry is Cholesgen Pharmaceutical in?
Cholesgen Pharmaceutical’s primary industry is Drug Discovery.
-
Is Cholesgen Pharmaceutical a private or public company?
Cholesgen Pharmaceutical is a Private company.
-
What is Cholesgen Pharmaceutical’s current revenue?
The current revenue for Cholesgen Pharmaceutical is
. -
How much funding has Cholesgen Pharmaceutical raised over time?
Cholesgen Pharmaceutical has raised $14.3M.
-
Who are Cholesgen Pharmaceutical’s investors?
Dawu Venture Capital, Gaorong Capital, Wuxi AstraZeneca CICC Venture Capital Partnership, and Trinity Innovation Fund have invested in Cholesgen Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »